Cardiotrophin-1 (CT-1), a newly discovered cytokine, has been shown to
induce cardiac hypertrophy in vitro and in vivo. The present study ex
amined the effects of CT-1 on haemodynamics and cardiac function, The
measurements of haemodynamic parameters were made using in-dwelling ca
theters and flow probes in conscious, unrestrained rats, Intravenous a
dministration of CT-1 caused a dose-dependent decrease in mean arteria
l pressure (MAP), and an increase in heart rate (HR), CT-1 (100 mu g/k
g) significantly elevated cardiac output and HR, and decreased MAP and
systemic vascular resistance, Stroke volume was unaltered, suggesting
that the CT-1-induced increase in cardiac output was secondary to inc
reased HR. There was no significant difference in left ventricular max
imal dP/dt between the CT-1-treated and vehicle-treated groups, sugges
ting that CT-1 might not induce a meaningful change in ventricular con
tractility, Pretreatment with intravenous N-omega-nitro-L-arginine met
hyl ester, a specific inhibitor of nitric oxide synthase, significantl
y attenuated the depressor and tachycardic responses to CT-1. These re
sults indicate that nitric oxide plays an important role in mediating
the haemodynamic effects of CT-1. (C) 1997 Academic Press Limited.